Featured Research

from universities, journals, and other organizations

Experimental vaccine elicits robust response against both HIV and tuberculosis, study suggests

Date:
May 21, 2012
Source:
American Society for Microbiology
Summary:
Clinician researchers have developed a vaccine that acts simultaneously against HIV-1 and M. tuberculosis). An estimated 14 million people worldwide are coinfected with the two pathogens.

Clinician researchers in China have developed a vaccine that acts simultaneously against HIV-1 and M. tuberculosis (Mtb). An estimated 14 million people worldwide are coinfected with the two pathogens. The research is published in the May 2012 issue of Clinical and Vaccine Immunology.

The vaccine is composed of antigens from both pathogens. The team, led by Sidong Xiong of Fudan University, Shanghai, incorporated four Mtb epitopes (the part of an antigen that is recognized by the immune system) into a backbone composed of HIV-1 p24 protein, a protein that is known to produce protective immunity against HIV-1. The logic of this construction: many epitopes are short peptides, with poor immunogenicity unless they are introduced into a carrier protein -- which in this case was the p24 protein.

The vaccine induced cellular immune responses to both pathogens, in which immune system cells including macrophages search out and destroy pathogens; and humoral immune response against HIV-1, in which the immune system produces antibodies against the pathogen. The vaccine was tested in a mouse model.

Tuberculosis is one of the leading causes of death worldwide; third, after hepatitis C and then HIV/AIDS among infectious diseases, according to the World Health Organization (WHO). An estimated 2 billion -- 28 percent of the world's population -- are infected with M. tuberculosis, but most of these infections are latent. However, HIV infection is the strongest risk factor for the progression of latent tuberculosis infection to active TB. And TB is the direct cause of death in about one quarter of all deaths among people with HIV/AIDS, according to the WHO.


Story Source:

The above story is based on materials provided by American Society for Microbiology. Note: Materials may be edited for content and length.


Journal Reference:

  1. R. Ben-Ami, K. Olshtain-Pops, M. Krieger, I. Oren, J. Bishara, M. Dan, Y. Wiener-Well, M. Weinberger, O. Zimhony, M. Chowers, G. Weber, I. Potasman, B. Chazan, I. Kassis, I. Shalit, C. Block, N. Keller, D. P. Kontoyiannis, M. Giladi. Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream Infection. Antimicrobial Agents and Chemotherapy, 2012; 56 (5): 2518 DOI: 10.1128/AAC.05947-11

Cite This Page:

American Society for Microbiology. "Experimental vaccine elicits robust response against both HIV and tuberculosis, study suggests." ScienceDaily. ScienceDaily, 21 May 2012. <www.sciencedaily.com/releases/2012/05/120521152645.htm>.
American Society for Microbiology. (2012, May 21). Experimental vaccine elicits robust response against both HIV and tuberculosis, study suggests. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2012/05/120521152645.htm
American Society for Microbiology. "Experimental vaccine elicits robust response against both HIV and tuberculosis, study suggests." ScienceDaily. www.sciencedaily.com/releases/2012/05/120521152645.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins